Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane R Parnes

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitisAnish Dsilva, Ariel Wagner, Michal Itan, et al.
Frontiers in Immunology|December 31, 2021
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and TargetMark A Kroenke, Troy E Barger, Jenny Hu, et al.
Nature Metabolism|February 5, 2024
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settingsMurielle M Véniant, Shu-Chen Lu, Larissa Atangan, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitisAnish Dsilva, Ariel Wagner, Michal Itan, et al.
Frontiers in Immunology|December 31, 2021
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and TargetMark A Kroenke, Troy E Barger, Jenny Hu, et al.
Nature Metabolism|February 5, 2024
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settingsMurielle M Véniant, Shu-Chen Lu, Larissa Atangan, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Pageof 5